Market Place
Sourcing Support
Priothera to Present Mocravimod Trial at ASH 2024
03 Dec 2024 //
GLOBENEWSWIRE
EUROAPI and Priothera enter into CDMO collaboration to advance oncology project
18 Jun 2024 //
PRESS RELEASE
Priothera “ US FDA grants Orphan Drug Designation to mocravimod
27 Nov 2023 //
GLOBENEWSWIRE
Priothera cleared to begin Japanese arm of pivotal PIII with mocravimod for AML
28 Feb 2023 //
BIOSPACE
Priothera announces first patients enrolled in Phase 2b/3 study with mocravimod
23 Jan 2023 //
PR NEWSWIRE
Priothera Receives FTD for mocravimod in Combination with HSCT
31 May 2022 //
PRNEWSWIRE
Priothera to start Phase IIb/III trial of acute myeloid leukaemia therapy
26 Apr 2022 //
CLINICALTRIALSARENA
Priothera Receives FDA clearance of (IND) to start Phase 2b/3
25 Apr 2022 //
PRNEWSWIRE
Priothera Receives Regulatory Approvals for Global Pivotal Study with Mocravimod
11 Apr 2022 //
PRNEWSWIRE
Priothera - FDA and EMA Grant ODD to mocravimod for AML in HSCT
02 Mar 2022 //
PRNEWSWIRE
As Biotech Cash Dries Up, Ireland`s Priothera Gets EU Backing For Leukemia Drug
23 Feb 2022 //
THE SCRIP
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.